Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD Moderna, Inc. Transaction History
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD
- $1.12 Billion
- Q1 2024
A detailed history of Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD holds 88,858 shares of MRNA stock, worth $10.4 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
88,858
Previous 88,858
-0.0%
Holding current value
$10.4 Million
Previous $8.84 Million
7.15%
% of portfolio
0.85%
Previous 0.61%
Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
1,037Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.23 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.57 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.97 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.69 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.13 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...